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Introduction:  Painless hematuria is the presenting symptom in 85–90% of patients with bladder cancer.
Objectives:  To evaluate the efficacy of voided urinary cytology and ultrasonography in the diagnosis and
follow up of bladder cancer compared to cystoscopy as a gold standard with reference to its grade. To
recommend a protocol that improves the overall sensitivity and specificity of detection of new cases and
recurrence in the follow up of patients with bladder cancer.
Subjects  and  methods:  A prospective analysis of patients with painless hematuria and follow up patients
of bladder cancer was done. They were subjected to voided urinary cytology and ultrasonography. The
results were compared with the inferences drawn from cystoscopy and histopathological examination of
the resected tumor, wherever applicable.
Results:  The sensitivity of urinary cytology and ultrasonography was 13.33% and 66.67%, respectively,
compared to cystoscopy as a gold standard, whereas the specificity of urinary cytology and ultrasonography
was 100% and 93.33%, respectively. Cytology was positive only in high grade cases.
Conclusions:  Voided urinary cytology can be omitted as a screening test. Ultrasonography can be recom-
mended as the initial imaging investigation for detection of bladder carcinoma in patients presenting with
hematuria and for follow up of bladder carcinoma patients.
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ntroductionladder cancer is the fourth most common cancer in men and the
inth most common cancer in women [1]. The commonest histo-
ogical variant is transitional cell carcinoma (TCC) and accounts
or more than 95% of all the cases of bladder cancer [2,3].
























































Efficacy of voided urinary cytology and ultrasonography 
Painless hematuria is the presenting symptom in 85–90% of patients
with bladder cancer [4]. The workup of suspected bladder cancer
should include cytology, a cystoscopy, and an upper tract study.
The most important modality for detection of bladder tumor in a
new patient with hematuria or a known patient of bladder cancer is
cystoscopic evaluation followed by histopathological examination
of resected tumor, if present.
Although cystoscopy is the gold standard for the detection of blad-
der cancer, the false negative results associated with cystoscopy
can range from 10 to 40%. Lesions of Carcinoma in situ (CIS)
may escape detection even by cystoscopy [5,6]. Also tumors of the
upper tract and very small bladder tumors at relatively less optimally
visualized areas on cystoscopy may be missed.
To overcome this, voided urine cytology is used as an adjunctive
test in identifying occult cancers that may be missed on cystoscopy.
It can identify exfoliated cells from both normal and neoplastic
urothelium and may be useful in detecting cancer in symptomatic
patients and assessing response to treatment. Detection rates are
high for tumors with high grade and stage as well as CIS [7,8].
Cytology is illustrative of the problems of non-invasive screening.
Poorly differentiated tumors have a 20% false-negative detection
rate, whereas well-differentiated tumors have up to an 80% false-
negative detection rate. Cytology, however, remains the preferred
bladder tumor marker for specificity [9].
Bladder cancer may also be detected by various imaging techniques.
CT urogram is the imaging modality of choice to detect bladder
masses. Large tumors can also be detected on ultrasonographic study
of the KUB region, in which case cystoscopy may be planned with
transurethral resection of bladder tumor.
The aim of our study was to evaluate the efficacy of voided urinary
cytology and ultrasonography in the diagnosis and follow up of
bladder cancer compared to cystoscopy as a gold standard with ref-
erence to its grade and to devise a protocol that improves the overall
sensitivity and specificity of detection of new cases and recurrence
in the follow up of patients with bladder cancer.
Subjects  and  methods
In this study, a prospective analysis of new and follow up patients
under evaluation for bladder cancer was done at urology center of
Command Hospital (EC), Kolkata from Feb 2013 to July 2014. Sixty
(60) patients being evaluated for Carcinoma Bladder both freshly
detected and those on follow-up were included as per convenience
sampling after obtaining their informed written consent.
Inclusion criteria were (1) patients of painless hematuria on evalu-
ation for bladder cancer, and (2) known patients of bladder cancer
under follow up. Following categories of patients were excluded
from the study: (1) patients with major co-morbidities requiring
acute intensive medical care, (2) patients with major psychiatric ill-
nesses, (3) benign inflammatory or infectious conditions of bladder,
(4) renal or bladder calculi, (5) foreign body (stent or nephrostomy
tube), (6) other genitourinary cancer, (7) recent instrumentation, (8)
bleeding disorders, (9) bowel interposition.
The study was approved by the ethical committee of the institute.




ecorded. Under structured pro forma in depth history of the patients
as taken to note the indication for which patient was being eval-
ated for Carcinoma Bladder and the duration of illness in known
ases of Carcinoma Bladder. Any past or concomitant co morbidity
as noted. Detailed clinical examination including vital parameters
ecording was done. Abdomen was examined thoroughly to look for
ny abnormality like swelling, tenderness, lump, etc. with special
eference to suprapubic region.
ll patients fulfilling the inclusion criteria were subjected to freshly
oided urinary cytology with 100 ml of random urine samples on
hree consecutive days. A well mixed sample of urine (12 ml) was
entrifuged in a centrifuge tube for 5 min at 1500 rpm and super-
atant was poured off. The tube was tapped at the bottom to
esuspend the sediment in 0.5 ml of urine. One drop of this sedi-
ent was placed on a glass slide and smear was made, which was
xed and stained with Pap stain. Another drop was placed on a sep-
rate slide and stained with Leishmann-Geimsa stain. The slides
ere examined immediately under the microscope using first the
ow power and then the high power objective. Malignant transi-
ional cells were seen having pleomorphic hyperchromatic nuclei,
igh nucleus: cytoplasmic ratio and moderate amount of cytoplasm.
maging of the KUB region in the form of ultrasonographic study
as done in all cases prior to cystoscopy. CECT/IVU was done as
nd when indicated. Ultrasonography was performed with Logiq P5
ith an electronic curved array transducer available in the radiology
epartment. Patients were asked to present with a full bladder. Ultra-
ound examination of the KUB region was performed on all patients.
he bladder was imaged with transverse and longitudinal scans with
he patient in the supine position. Scanning was performed both pre
nd post micturition.
his was followed by cystoscopy with transurethral resection of
esions, if found and their histopathological examination. The blad-
er was evacuated before cystoscopy. Under local anaesthesia with
he patient in lithotomy position, after proper cleaning and draping,
 Karl Storz 19 Fr rigid cystoscope with 30◦ lens was introduced
ith prophylactic antibiotic cover and the entire urinary bladder
as inspected systematically. The tumor(s) if found was mapped
iagrammatically over the data collection sheet. If tumor was found
n cystoscopy or in patients with tumor visible during ultrasonogra-
hy, transurethral resection of bladder tumor was done under spinal
naesthesia (under general anaesthesia, if growth was on lateral
ladder wall to avoid obturator jerk during surgery). A 26 Fr con-
inuous flow rotating sheath resectoscope was used and the tumor
as completely resected, proper haemostasis was done and resected
issue was sent for histopathological examination. Finally examina-
ion under anaesthesia was done again for clinical staging. A 3-way
oley’s catheter (22Fr) was placed per urethrally and irrigation with
ormal saline was started if hematuria was present.
he results were compared with the inferences drawn from cys-
oscopy and histopathological examination of the resected tumor,
herever applicable. Histologically confirmed urothelial carcinoma
as graded according to WHO/ISUP consensus classification [10].
he findings were analyzed in terms of sensitivity, specificity, pos-
tive predictive value and negative predictive value of voided urine
ytology and imaging in the diagnosis of Carcinoma Bladder with
espect to grade keeping cystoscopy as the gold standard. The results
ere collected, evaluated, calculated, tabulated and statistically ana-
194 N. Kumar et al.
Table  1  Demographic data and clinical characteristics of patients.
Mean age (min–max) 48.1 (21–82)
Gender
Male 56 (93.33%)
Female 04 (6. 66%)
Indication for evaluation
Painless hematuria 48 (80%)








Table  2  Comparison of imaging with cystoscopy.





Imaging positive 20 02 22
Imaging negative 10 28 38
Total 30 30 60































Table  4  Comparison of imaging versus voided urine cytology.















Table  5  Imaging and urinary cytology in diagnosis of bladder
tumor as per histological grade.







Imaging positive 10 10
Imaging negative 9 01
Voided urinary cytology positive 00 04
Voided urinary cytology negative 19 07
Table  6  Grade wise comparison of sensitivity of imaging and
voided urine cytology.
Grade Sensitivity
Low grade High grade
Imaging 52.63% 90.91%




















Total 30 30 60
yzed using a Chi-square test. P value less than 0.05 was considered
ignificant.
esults
ixty (60) patients of Carcinoma urinary bladder, both freshly
etected and those on follow-up were included in the study. The
ean age of the patients was 48.1 years ±  16.05 years with a range of
1–82 years. Table 1 shows demographic and clinical characteristics
f the patients.
ut of the 60 cases enrolled in the study, 30 were found to have
o growth on cystoscopy. The remaining 30 patients were found
o have bladder growth on cystoscopy for which they underwent
ransurethral resection followed by histopathological examination
f the resected tissue. Out of these 30 cases, 19 patients had low
rade urothelial carcinoma and 11 patients had high grade tumor.
ll 60 patients included in the study underwent imaging of the KUB
egion in the form of ultrasonographic study. It was positive in 22
ases and negative in 38 cases. Few patients also underwent CECT
UB region or IVU as per the indications (Tables 2–6).oided urine cytology was done in all 60 cases. It was negative
n 56 cases. It was positive in 4 cases. Out of the 56 cases which




ladder cancer on histopathological examination. All 4 cases found
ositive on cytology were confirmed to have bladder cancer on
istopathological examination.
sing McNemar Chi-square test, McNemar Chi-squared statistic
ith Yates correction of 1.0 was 24.038462 with corresponding p-
alue being 0.000001, which implies that the difference between
he sensitivity and specificity of imaging and urinary cytology is
tatistically significant (p < 0.05).
he differences between sensitivity, specificity and positive predic-
ive value of imaging and voided urinary cytology were statistically
ignificant, as reflected by the non overlap of the 95% confidence
ntervals, whereas the difference between negative predictive values
as not statistically significant.
ut of 60 patients, biopsy was done in 30 cases as the rest of the
ases had no visible growth on cystoscopy. 19 patients had low
rade papillary urothelial neoplasm and 11 patients had high grade
eoplasm. Among 19 patients with low grade cancers, imaging was
ositive in 10 cases as compared to voided urine cytology which was
ot positive in any case. In 11 high grade cancer patients, imaging
as positive in 10 cases where as voided urine cytology was positive




































Efficacy of voided urinary cytology and ultrasonography 
Discussion
A total of 60 cases were included in this study. Mean age of patients
was 50 years, commensurate with it being common in middle aged
and elderly people.
The distribution of patients according to gender revealed that only
23.33% patients under study were female, thus reflecting the male-
to-female ratio of bladder cancer prevalence being nearly 3:1 and
the disparities in case reporting and loss of patients to attrition due
to lack of awareness about the disease.
The overall sensitivity of voided urinary cytology was found to be
13.33%. The factors affecting the sensitivity of urinary cytology
include specimen quality, number of exfoliated cells, and pathol-
ogist’s expertise. Also inflammatory conditions of the bladder can
confound the results, so patients with inflammatory conditions of
bladder were excluded from the study.
On the other hand, imaging had a sensitivity of 66.67% which was
significantly higher than that of cytology. This is in accordance
with previous observations that ultrasonography has not proven
itself as an accurate tool for detecting small flat tumors and CIS
[11,12]. However, transabdominal ultrasonography is a simple and
inexpensive imaging modality. It is not associated with contrast
administration and its risks viz allergic reaction or nephropathy. Fac-
tors affecting the diagnosis of bladder tumor on ultrasound include
the operator’s skill, amount of abdominal fat and bladder distension
during procedure. So, ultrasonography may prove a useful adjunct
to cystoscopy as a screening test for bladder tumor. We recommend
transabdominal ultrasound as the initial investigation for detecting
bladder carcinoma in patients presenting with painless hematuria
and for followup of bladder carcinoma patients.
The overall specificity of urine cytology was 100% and was found to
be higher than that of imaging (93.33%). Most studies have similarly
reported very high specificity of urinary cytology [12–18]. However,
the specificity of ultrasonography as the basic imaging modality in
this study was also found to be comparable to that of cytology.
The positive predictive value of urine cytology was found to be
100%, significantly higher compared to PPV of imaging (90.91%).
All patients who had positive urinary cytology for malignant cells
were positive for bladder tumor on imaging. The negative predic-
tive value of urinary cytology in the present study was 53.57% and
was lower than that of imaging (73.68%). However, the difference
between the NPV of both tests was not statistically significant, as
evident by overlapping of 95% confidence intervals of NPV of both
tests.
The positive likelihood ratio of imaging was calculated to be 10
whereas the positive likelihood ratio of urinary cytology was found
to be infinity. So, if either imaging or urinary cytology would be
reported as positive, there would be very high likelihood of blad-
der tumor evident on cystoscopy (LR+ > 10). So if malignant cells
are seen in a patient’s urine, there is almost 100% possibility of
bladder tumor being present and the patient may directly be taken
for cystoscopy and transurethral resection of bladder tumor. Patients
diagnosed to have bladder carcinoma on ultrasound should be further
evaluated promptly with cystoscopy and histopathological exami-




he negative likelihood ratio of imaging was calculated to be 0.357
hereas the negative likelihood ratio of urinary cytology was found
o be 0.867. So if imaging would be negative, there would be small
ecrease in likelihood of bladder tumor being found on cystoscopy
LR−  0.2–0.5), while if voided urinary cytology was negative in a
atient, there would be minimal decrease in likelihood of bladder
umor being found on cystoscopy (LR− 0.5–1.0).
n grade wise evaluation, the sensitivity of imaging was lower
or low grade tumors (52.63%) as compared to high grade tumors
90.91%).
oided urine cytology had a sensitivity of 0% in case of low grade
umors and sensitivity of 36.36% for high grade tumors. There are
wo main reasons for such low sensitivity [19]. First, tumor cells of
he low grade tumors are not routinely shed into the urine because
f their cohesive nature. Second, and probably more important,
s the fact that low grade tumor cells by definition have similar
ytomorphology to normal urothelial cells microscopically [19].
he sensitivity of voided urine cytology is too low to justify its
ontinuing use in evaluation of bladder carcinoma, especially low
rade. Cytology may still be used because of its higher sensitivity
n detecting high grade tumors and carcinoma in-situ.
arious studies have shown that the sensitivity of voided urine cytol-
gy is particularly low for low grade and is around 80% for high
rade tumors. Overall sensitivities reported for urinary cytology are
n the order of 7–65% [12–17,20].
onclusions
. Voided urinary cytology can be omitted as a screening test owing
to its very low sensitivity (13.33%), high cost and requirement
of pathological facilities.
. Ultrasonography as an imaging modality can be recommended
as the initial investigation for detection of bladder carcinoma in
patients presenting with hematuria and for followup of bladder
carcinoma patients.
. Patients suspected to be suffering from bladder carcinoma by
urinary cytology (in cases where it is performed) and by imaging
should be scheduled directly and promptly for cystoscopy and
bladder tumor resection, based on their high specificity (93.33%
and 100%, respectively).
. Imaging is significantly more sensitive compared with cytology
in both low and high grade tumors, although imaging cannot be
relied upon in low grade tumors.
. Cystoscopy cannot be replaced even by dynamic transabdominal
ultrasonography in the diagnosis or followup of patients with
bladder tumors.
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